These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34469564)

  • 1. Global Rotavirus and Pneumococcal Conjugate Vaccine Introductions and the Association With Country Disease Surveillance, 2006-2018.
    Peck ME; Hampton LM; Antoni S; Ogbuanu I; Serhan F; Nakamura T; Walldorf JA; Cohen AL
    J Infect Dis; 2021 Sep; 224(12 Suppl 2):S184-S193. PubMed ID: 34469564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of pneumococcal conjugate vaccine and rotavirus vaccine introduction into the South African public immunisation programme.
    Madhi SA; Bamford L; Ngcobo N
    S Afr Med J; 2014 Mar; 104(3 Suppl 1):228-34. PubMed ID: 24893498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of uptake of newly introduced vaccines in Malawi - monovalent human rotavirus and pneumococcal conjugate vaccines: Evidence from the 2015-16 Malawi demographic and health survey.
    Ntenda PAM; Mwenyenkulu ET; Putthanachote N; Nkoka O; Mhone TG; Motsa MPS; Tizifa T
    J Trop Pediatr; 2019 Jun; 65(3):287-296. PubMed ID: 30085260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using pneumococcal and rotavirus surveillance in vaccine decision-making: A series of case studies in Bangladesh, Armenia and the Gambia.
    Hasan AZ; Saha S; Saha SK; Sahakyan G; Grigoryan S; Mwenda JM; Antonio M; Knoll MD; Serhan F; Cohen AL;
    Vaccine; 2018 Aug; 36(32 Pt B):4939-4943. PubMed ID: 30037484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocontribution of Rotavirus and Pneumococcal Conjugate Vaccines to the Reduction of Pediatric Hospital Visits in Young Children.
    Ben-Shimol S; Givon-Lavi N; Greenberg D; Dagan R
    J Pediatr; 2017 Mar; 182():253-259.e2. PubMed ID: 27939127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study.
    Mackenzie GA; Hill PC; Jeffries DJ; Hossain I; Uchendu U; Ameh D; Ndiaye M; Adeyemi O; Pathirana J; Olatunji Y; Abatan B; Muhammad BS; Fombah AE; Saha D; Plumb I; Akano A; Ebruke B; Ideh RC; Kuti B; Githua P; Olutunde E; Ofordile O; Green E; Usuf E; Badji H; Ikumapayi UNA; Manjang A; Salaudeen R; Nsekpong ED; Jarju S; Antonio M; Sambou S; Ceesay L; Lowe-Jallow Y; Jasseh M; Mulholland K; Knoll M; Levine OS; Howie SR; Adegbola RA; Greenwood BM; Corrah T
    Lancet Infect Dis; 2016 Jun; 16(6):703-711. PubMed ID: 26897105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries.
    Marijam A; Schuerman L; Izurieta P; Pereira P; Van Oorschot D; Mehta S; Ota MO; Standaert B
    Hum Vaccin Immunother; 2022 Dec; 18(7):2135916. PubMed ID: 36507685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the economic impact of pneumococcal conjugate, Haemophilus influenzae type b and rotavirus vaccines in India: National and state-level analyses.
    Constenla D; Liu T
    Vaccine; 2019 Dec; 37(52):7547-7559. PubMed ID: 31607600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda.
    Tate JE; Kisakye A; Mugyenyi P; Kizza D; Odiit A; Braka F
    Vaccine; 2011 Apr; 29(17):3329-34. PubMed ID: 21241733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global invasive bacterial vaccine-preventable diseases surveillance--2008-2014.
    Murray J; Agócs M; Serhan F; Singh S; Deloria-Knoll M; O'Brien K; Mwenda JM; Mihigo R; Oliveira L; Teleb N; Ahmed H; Wasley A; Videbaek D; Wijesinghe P; Thapa AB; Fox K; Paladin FJ; Hajjeh R; Schwartz S; Van Beneden C; Hyde T; Broome C; Cherian T;
    MMWR Morb Mortal Wkly Rep; 2014 Dec; 63(49):1159-62. PubMed ID: 25503919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The direct effect of pneumococcal conjugate vaccines on invasive pneumococcal disease in children in the Latin American and Caribbean region (SIREVA 2006-17): a multicentre, retrospective observational study.
    Agudelo CI; Castañeda-Orjuela C; Brandileone MCC; Echániz-Aviles G; Almeida SCG; Carnalla-Barajas MN; Regueira M; Fossati S; Alarcón P; Araya P; Duarte C; Sánchez J; Novas M; Toraño-Peraza G; Rodríguez-Ortega M; Chamorro-Cortesi G; Kawabata A; García-Gabarrot G; Camou T; Spadola E; Payares D; Andrade AL; Di Fabio JL; Castañeda E;
    Lancet Infect Dis; 2021 Mar; 21(3):405-417. PubMed ID: 32986996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
    Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preventable burden of pneumococcal disease in the developing world.
    Scott JA
    Vaccine; 2007 Mar; 25(13):2398-405. PubMed ID: 17028081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: South Africa, 2003-2008.
    von Gottberg A; Cohen C; de Gouveia L; Meiring S; Quan V; Whitelaw A; Crowther-Gibson P; Madhi SA; Whitney CG; Klugman KP
    Vaccine; 2013 Aug; 31(38):4200-8. PubMed ID: 23684826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods and challenges in measuring the impact of national pneumococcal and rotavirus vaccine introduction on morbidity and mortality in Malawi.
    Bar-Zeev N; Kapanda L; King C; Beard J; Phiri T; Mvula H; Crampin AC; Mwansambo C; Costello A; Parashar U; Tate JE; Verani JR; Whitney CG; Heyderman RS; Cunliffe NA; French N;
    Vaccine; 2015 May; 33(23):2637-45. PubMed ID: 25917672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The composition of demand for newly launched vaccines: results from the pneumococcal and rotavirus vaccine introductions in Ethiopia and Malawi.
    Williams BA; Kidane T; Chirwa G; Tesfaye N; Prescott MR; Scotney ST; Valle M; Abebe S; Tambuli A; Malewezi B; Mohammed T; Kobayashi E; Wootton E; Wong R; Dosani R; Subramaniam H; Joseph J; Yavuz E; Apple A; Le Tallec Y; Kang'ethe A
    Health Policy Plan; 2016 Jun; 31(5):563-72. PubMed ID: 26856361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rota and pneumococcus vaccine success stories: pediatric emergency practitioners wonder "where have the kids gone?".
    McKenna M
    Ann Emerg Med; 2009 Apr; 53(4):23A-25A. PubMed ID: 19320052
    [No Abstract]   [Full Text] [Related]  

  • 18. Expansion of Vaccination Services and Strengthening Vaccine-Preventable Diseases Surveillance in Haiti, 2010-2016.
    Tohme RA; Francois J; Cavallaro KF; Paluku G; Yalcouye I; Jackson E; Wright T; Adrien P; Katz MA; Hyde TB; Faye P; Kimanuka F; Dietz V; Vertefeuille J; Lowrance D; Dahl B; Patel R
    Am J Trop Med Hyg; 2017 Oct; 97(4_Suppl):28-36. PubMed ID: 29064356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands.
    Knol MJ; Wagenvoort GH; Sanders EA; Elberse K; Vlaminckx BJ; de Melker HE; van der Ende A
    Emerg Infect Dis; 2015 Nov; 21(11):2040-4. PubMed ID: 26488415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. South Asia symposium on pneumococcal disease and the promise of vaccines - Meeting report.
    Kumar R; Arora N; Santosham M
    Vaccine; 2016 May; 34(23):2622-6. PubMed ID: 27026150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.